ORYZON to Present at the Neuroscience R&D Technologies Conference

BARCELONA, Spain and CAMBRIDGE, Mass., Nov. 30, 2015 (GLOBE NEWSWIRE) — Oryzon Genomics, a clinical stage biopharmaceutical company leveraging epigenetics to develop therapies in oncology and neurodegenerative diseases, announced today that Dr. Tamara Maes, Oryzon’s Chief Scientific Officer, will present at the Neuroscience R&D Technologies Conference on December 3 – 4, to be held at Hotel Pullman Barcelona Skipper in Barcelona, Spain.Dr. Maes will be delivering a presentation on the “Role of epigenetics in neurodegenerative disease in general and development of LSD1 inhibitors in particular” on Friday, December 4 at 14:05 pm-14:35 pm. The presentation is part of a broader session that will discuss the recent advancements in next generation neuroscience research.”LSD1 inhibitors represent a novel approach to potential treatments of neurodegenerative diseases. We are very excited to share our…

Link to Full Article: ORYZON to Present at the Neuroscience R&D Technologies Conference

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!